HAL (France)open access
Enhancing brain delivery of tegaserod for Alzheimer’s disease: a pharmaceutical comparison of two nanocarrier-based strategies
Brain delivery, 0, Alzheimer’s disease, 1, 2, Blood-brain barrier, Nose-to-brain administration, Lipid-based nanovectors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 388152
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.